Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | revenue | rating |
---|---|---|---|---|---|---|---|
Adaptive Biotechnologies Corporation | $3.55 | $532.00 M | -2.42 | 709 | $170.28 M | ||
Apellis Pharmaceuticals, Inc. | $36.26 | $4.90 B | -11.77 | 702 | $396.59 M | ||
AVROBIO, Inc. | $1.40 | $68.24 M | 2.2 | 13 | $0 | ||
C4 Therapeutics, Inc. | $4.51 | $320.64 M | -1.97 | 145 | $20.76 M | ||
Celcuity Inc. | $16.86 | $501.59 M | -5.14 | 55 | $0 | ||
Cullinan Oncology, Inc. | $16.15 | $1.29 B | -7.16 | 85 | $0 | ||
CNS Pharmaceuticals, Inc. | $1.27 | $1.20 M | -0.01 | 3 | $0 | ||
Decibel Therapeutics, Inc. | $4.91 | $123.37 M | -1.93 | 68 | $0 | ||
Ginkgo Bioworks Holdings, Inc. | $0.34 | $1.14 B | -1.2 | 1218 | $251.46 M | ||
Edgewise Therapeutics, Inc. | $19.43 | $1.65 B | -11.47 | 92 | $0 | ||
Freeline Therapeutics Holdings plc | $6.49 | $28.28 M | -0.57 | 152 | $0 | ||
Hepion Pharmaceuticals, Inc. | $1.06 | $6.02 M | -0.12 | 22 | $0 | ||
Werewolf Therapeutics, Inc. | $2.09 | $151.66 M | -3.17 | 46 | $19.94 M | ||
Immix Biopharma, Inc. | $2.37 | $53.62 M | -2.18 | 14 | $0 | ||
Kronos Bio, Inc. | $1.15 | $44.62 M | -0.37 | 61 | $6.29 M | ||
Kezar Life Sciences, Inc. | $0.58 | $49.85 M | -0.49 | 58 | $7.00 M | ||
Legend Biotech Corporation | $46.32 | $8.31 B | -17.66 | 2000 | $285.14 M | ||
Nkarta, Inc. | $5.18 | $465.09 M | -2.81 | 150 | $0 | ||
Ocean Biomedical, Inc. | $1.07 | $50.07 M | -0.48 | 9 | $0 | ||
Prime Medicine, Inc. | $5.25 | $788.60 M | -3.01 | 234 | $0 | ||
Royalty Pharma plc | $25.69 | $12.41 B | 15.43 | 75 | $2.35 B | ||
Summit Therapeutics Inc. | $7.23 | $5.42 B | 20.32 | 105 | $0 | ||
Vir Biotechnology, Inc. | $8.52 | $1.53 B | -2.8 | 587 | $86.18 M |